Ariadne Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Buy
1,234
+82
+7% +$83.1K 0.51% 41
2025
Q4
$1.2M Sell
1,152
-4
-0.3% -$3.83K 0.49% 44
2025
Q3
$1.18M Buy
1,156
+26
+2% +$19.3K 0.53% 45
2025
Q2
$746K Sell
1,130
-93
-8% -$72.3K 0.36% 61
2025
Q1
$899K Buy
1,223
+20
+2% +$16.6K 0.47% 55
2024
Q4
$1.05M Buy
1,203
+82
+7% +$67.9K 0.48% 51
2024
Q3
$894K Buy
+1,121
New +$1.01M 0.49% 42

Other funds holding LLY

Ariadne Wealth Management's LLY Position: Q1 2026 in Review

Ariadne Wealth Management increased its Eli Lilly (LLY) stake by 7.1% in Q1 2026, buying an estimated $83.1K and bringing the position to 1,234 shares worth $1.14M. The position accounts for 0.51% of the portfolio, ranked #41.

Ariadne Wealth Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ariadne Wealth Management held 1,234 shares of Eli Lilly worth $1.14M as of Q1 2026.
  • Ariadne Wealth Management bought 82 Eli Lilly shares in Q1 2026, an estimated $83.1K.
  • Eli Lilly made up 0.51% of Ariadne Wealth Management's portfolio in Q1 2026, its #41 holding.
  • Ariadne Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Ariadne Wealth Management's Eli Lilly position peaked at $1.2M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.